159 related articles for article (PubMed ID: 11399815)
41. The impact of temporary deferrals on future blood donation behavior across the donor life cycle.
Clement M; Shehu E; Chandler T
Transfusion; 2021 Jun; 61(6):1799-1808. PubMed ID: 33780022
[TBL] [Abstract][Full Text] [Related]
42. Assessment of pre and post donation changes in hematological parameters and serum calcium and magnesium levels in plateletpheresis donors.
Syal N; Kukar N; Arora H; Kaur A; Handa A; Maharishi RN
J Family Med Prim Care; 2022 Apr; 11(4):1489-1492. PubMed ID: 35516708
[TBL] [Abstract][Full Text] [Related]
43. Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010-2019: A favorable sign of the resiliency of the platelet supply.
Lasky B; Singh U; Young PP
Transfusion; 2023 Jul; 63(7):1333-1343. PubMed ID: 37191295
[TBL] [Abstract][Full Text] [Related]
44. Switching iron-deficient whole blood donors to plateletpheresis.
O'Meara A; Infanti L; Sigle J; Stern M; Buser A
Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
[TBL] [Abstract][Full Text] [Related]
45. Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors.
Tuan HTM; Hock LS; Abdullah ZW
J Taibah Univ Med Sci; 2018 Apr; 13(2):180-187. PubMed ID: 31435321
[TBL] [Abstract][Full Text] [Related]
46. Changes in Hematological Indices and Lymphocyte Subsets in Response to Platelet Apheresis Donation.
Borai A; Bahijri S; Almohammadi M; Al-Sofyani A; Baljoon D; Al-Amri A; Boraie S; Ferns G
Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013347
[TBL] [Abstract][Full Text] [Related]
47. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
[TBL] [Abstract][Full Text] [Related]
48. Plateletpheresis efficiency and mathematical correction of software-derived platelet yield prediction: A linear regression and ROC modeling approach.
Jaime-Pérez JC; Jiménez-Castillo RA; Vázquez-Hernández KE; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
J Clin Apher; 2017 Oct; 32(5):329-334. PubMed ID: 27862253
[TBL] [Abstract][Full Text] [Related]
49. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
Gupta AM; Bajpai M
J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
[TBL] [Abstract][Full Text] [Related]
50. Reference interval of platelet counts and other platelet indices in apparently healthy blood donors in North India according to Clinical and Laboratory Standards Institute guidelines: Need to redefine the platelet count cutoffs for repeat plateletpheresis donation?
Pabbi S; Tiwari AK; Aggarwal G; Sharma G; Marik A; Luthra AS; Upadhyay AP; Singh MK
Asian J Transfus Sci; 2022; 16(2):245-250. PubMed ID: 36687539
[TBL] [Abstract][Full Text] [Related]
51. Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors.
Hans R; Sharma RR; Marwaha N
Asian J Transfus Sci; 2019; 13(1):10-16. PubMed ID: 31360004
[TBL] [Abstract][Full Text] [Related]
52. T-cell lymphopenia in frequent volunteer platelet donors.
Kaufman RM
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):305-310. PubMed ID: 38066852
[TBL] [Abstract][Full Text] [Related]
53. Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.
Williams D; Rao M; Carey P
J Clin Apher; 2012; 27(4):205-11. PubMed ID: 22535678
[TBL] [Abstract][Full Text] [Related]
54. The post-platelet 100,000 count: effects of platelet collection and future.
Jaben EA; Gandhi MJ
J Clin Apher; 2011; 26(1):53-5. PubMed ID: 21312259
[TBL] [Abstract][Full Text] [Related]
55. Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors.
Sumner SM; Naskou MC; Thoresen M; Copland I; Peroni JF
Transfusion; 2017 Jul; 57(7):1755-1762. PubMed ID: 28439897
[TBL] [Abstract][Full Text] [Related]
56. Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis.
Unay Demirel O; Ignak S; Buyukuysal MC
Indian J Hematol Blood Transfus; 2018 Oct; 34(4):684-690. PubMed ID: 30369741
[TBL] [Abstract][Full Text] [Related]
57. Changes in pre- and post-donation platelet function in plateletpheresis donors.
Zhou Q; Yu X; Cai Y; Liu L
Transfus Clin Biol; 2017 Nov; 24(4):417-421. PubMed ID: 28599950
[TBL] [Abstract][Full Text] [Related]
58. Feasibility of high-yield plateletpheresis in routine practice: Experience from tertiary health center from South India.
Sahoo D; Noushad S; Basavarajegowda A; Toora E
Asian J Transfus Sci; 2023; 17(1):34-40. PubMed ID: 37188018
[TBL] [Abstract][Full Text] [Related]
59. Effect of double dose plateletpheresis on target yield and donor platelet recovery.
Chopra S; Kaur P; Bedi RK; Kaur G
Hematol Transfus Cell Ther; 2023; 45(1):16-24. PubMed ID: 34294601
[TBL] [Abstract][Full Text] [Related]
60. The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.
Gupta AM; Bajpai M
J Clin Apher; 2021 Aug; 36(4):621-627. PubMed ID: 33942928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
